Kinoxis Therapeutics
PrivateLast Round
Grant
Dec 23, 2024
Total Funding Raised
$22.2M
Company Overview
Kinoxis Therapeutics is a biotechnology company developing novel therapies for behavioural and psychological symptoms in neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinoxis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Kinoxis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 23, 2024 | ||||
| Series B | Aug 12, 2024 | ||||
| Grant | Jun 8, 2023 | ||||
| VC Round | Dec 22, 2020 | ||||
| Grant | Sep 29, 2019 | ||||
Series A | Feb 14, 2018 |
Key People
Founding team and executive leadership
Kinoxis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse (NIDA) | Grant |
| Medical Research Commercialisation Fund | Grant |
| Avicella Capital | Series B |
| National Institutes of Health (NIH) | Grant |
| Uniseed | VC Round, Series B, Series A |
Kinoxis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinoxis Therapeutics's valuation, stock price, and market status.
